Table 2.
Sunitinib (N = 12) | |
---|---|
Treatment cycles started, median (range) | 16 (3–21) |
Months on treatment, median (range) | 10 (0.7–18) |
Months on study, median (range) | 14 (0.7–19) |
No. of patients with ≥1 dosing interruption, n (%) | 11 (92) |
No. of patients with ≥1 dose reduction, n (%) | 8 (67) |
Relative dose intensity, median (range), % | 51 (26–94) |